# Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen

> **NCT00764322** · PHASE2 · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 501 (actual)

## Conditions studied

- Breast Cancer
- Menopausal Symptoms

## Interventions

- **DRUG:** tamoxifen citrate
- **GENETIC:** gene expression analysis
- **OTHER:** pharmacogenomic studies
- **OTHER:** questionnaire administration
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00764322
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06-18
- **Primary completion:** 2010-09-28
- **Final completion:** 2011-07-01
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2017-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00764322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00764322, "Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00764322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*